MedPath
HSA Approval

HYDROZIDE TABLET 50 mg

SIN01959P

HYDROZIDE TABLET 50 mg

HYDROZIDE TABLET 50 mg

April 21, 1988

ATLANTIC PHARMACEUTICAL (S) PTE LTD

ATLANTIC PHARMACEUTICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence HolderATLANTIC PHARMACEUTICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C03AA03

hydrochlorothiazide

Manufacturer Information

atlantic pharmaceutical (s) pte ltd

ATLANTIC LABORATORIES CORPN LTD

Active Ingredients

HYDROCHLOROTHIAZIDE

50 mg

Hydrochlorothiazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYDROZIDE TABLET 50 mg - HSA Approval | MedPath